Farallon Capital Management LLC Agios Pharmaceuticals, Inc. Call Options Transaction History
Farallon Capital Management LLC
- $17.4 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AGIO
# of Institutions
233Shares Held
60MCall Options Held
263KPut Options Held
307K-
Vanguard Group Inc Valley Forge, PA5.68MShares$201 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$172 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$124 Million2.39% of portfolio
-
State Street Corp Boston, MA2.45MShares$86.7 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.3MShares$81.4 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.94B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...